Background
==========

Since 1982, National Chung-Hsing University is maintaining six local chicken breeds: Hsin-Yi, Ju-Chi and Hua-Tung were collected from small villages in Taiwan, Quemoy was collected from Quemoy Island near China, Shek-Ki was from China, and Nagoya was from Japan \[[@B1]\]. In previous studies, Quemoy had significantly higher antibody titers against Newcastle Disease (ND) after vaccination than other local breeds, Shek-Ki, Hua-Tung and Ju-Chi had lower anti-ND antibody titers \[[@B2]\]. Thus, immune response was shown to differ within this set of local chicken breeds.

H6N1 Low pathogenic Avian Influenza Virus (LPAIV) is frequently isolated in Taiwan and lead to significant economic losses, either directly or indirectly through association with other infectious diseases \[[@B3]\]. This study investigated immune responses to ND, Infectious Bronchitis (IB) and Infectious Bursal Disease (IBD) vaccines following a H6N1 LPAIV challenge on six local chicken breeds and SPF chicken.

Methods
=======

Experimental chickens
---------------------

In this study we used the six local breeds and added an SPF White Leghorn as a control genotype.

A total of 314 chicks were hatched from 23 sires and 91 dams with full pedigree in six local breeds. Twenty-five SPF chicks were purchased from Animal Health Research Institute (Council of Agriculture, Executive Yuan R.O.C.). Day-old chicks were wing-banded and raised in floor pens until 5 weeks of age, and they were transferred to experimental cages after 6 weeks of age. Sire families were distributed between the control and the challenge group. Individual body weights were recorded weekly from hatch to 16 weeks of age.

Vaccination program and challenge
---------------------------------

Day-old chicks were all vaccinated against Marek's disease and ND. At two weeks of age, chicks were vaccinated against ND, IB, IBD, Fowl Pox and Avian Reovirus infection. At four weeks of age, chickens were vaccinated against ND, IB, IBD and Infectious Laryngotracheitis. The H6N1 LPAIV (A/chicken/Taiwan/0825/2006) challenge was performed at 7 weeks of age, birds from the challenge group received a drop with 10^7^ EID~50~ of viruses into eye and nose. Blood samples were collected at days 0, 7, 14 and 21 post-challenge. Chickens health condition and mortality were recorded and monitored. At 11 weeks of age, all chickens, from both challenge and control groups, were vaccinated again against ND, IB and IBD, blood samples were collected at days 0, 14 and 28 post-inoculation. Sera from blood samples were collected and stored in -20 *°*C refrigerator.

Immune response measurement
---------------------------

The antibody responses to H6N1 LPAIV, IBD and IB were measured by enzyme-linked immunosorbent assay (ELISA) with commercial test kit (IDEXX Laboratories, Inc., Westbrook, ME), the antibody titer calculation was performed according to IDEXX's formula. The antibody responses to ND were measured by hemagglutination inhibition test (HIT), the antibody titer was expressed as the log2 of the reciprocal of the highest dilution. Each measure was defined by the virus name (AI, ND, IBD or IB) and the day of sampling after inoculation (either days 0, 7, 14, 21 or 28). In addition, response to IB vaccine was calculated by the difference in antibody titers between stages, i.e. day 0 to day 14, day 14 to day 28 and day 0 to day 28.

Statistical analysis
--------------------

Antibody titers and differences between successive titers were analysed with the following statistical model,

where *Y~ijkl~* is the antibody titer of the *l*th animal of the *i*th breed, the *k*th sex after the *j*th challenge treatment, *i*=1, 2,...,7, *j*=1,2, *k*=1,2, *l*=1,2,...,338, *μ* is the mean, *τ~i~* is the fixed effect of the *i*th breed, Σ*τ~i~*=0, *α~j~* is the fixed effect of the *j*th challenge treatment, Σ*α~j~*=0, (*τα*)*~ij~* is the fixed interaction effect between the *i*th breed and the *j*th challenge treatment , ΣΣ(*τα*)*~ij~*=0, and *e~ijkl~* is the residual random error, .

All statistical analyses were conducted by using SAS software (SAS Institute).

Results
=======

H6N1 LPAIV challenge
--------------------

There was no mortality for Quemoy, Nagoya and SPF chickens (Table [1](#T1){ref-type="table"}). Ju-Chi, Hua-Tung and Shek-Ki exhibited a low mortality (one bird each), and Hsin-Yi had the highest mortality: 7 birds (22.6%, see Table [1](#T1){ref-type="table"}). Most of mortality occurred between day 7 and 14 post-challenge. The analysis of variance showed a significant effect of breed on all antibody titers, no effect of sex, and a significant effect of the challenge with a significant breed with challenge interaction on antibody titers from day 7 (Fig [1](#F1){ref-type="fig"}). This interaction was due to differential response between breeds: Quemoy had the highest antibody titer on day 7 and 14 post-challenge, Hua-Tung showed the highest antibody titer on day 21 post-challenge, Nagoya and SPF showed lower antibody titer on day 14 and 21 post-challenge. Quemoy was the only breed to exhibit a significant antibody titer at day 7 post-challenge. The anti-AI antibody titers were significantly higher for all breeds at days 14 and 21 post-challenge.

###### 

Sample size and mortality per breed in H6N1 challenge experiment

                       Hsin-Yi   Ju-Chi   Hua-Tung   Quemoy   Shek-Ki   Nagoya   SPF
  -------------------- --------- -------- ---------- -------- --------- -------- -----
  Control group        31        25       23         42       9         15       12
  Challenge group      31        27       28         49       12        22       12
  Total size           62        52       51         91       21        37       24
  Mortality^\*^        7         1        1          0        1         0        0
  Mortality rate (%)   22.6      3.7      3.6        0        8.3       0        0

^\*^ Mortality was calculated within challenge group.

![**Antibody titers against H6N1 LPAIV on 0, 7, 14 and 28 days post-challenge.**^a,b^ within days post-challenge with no common superscript differ significantly (*P* \< 0.05) in Quemoy. ^\*^ means all breeds have significantly different between control and challenge group.](1753-6561-5-S4-S33-1){#F1}

ND vaccine response
-------------------

There was no effect of the H6N1 LPAIV challenge on anti-ND antibody titers at day 14 and 28 post-inoculation (Fig [2](#F2){ref-type="fig"}). Nagoya was the only one to show a difference of anti-ND antibody titer between the control and challenge groups at day 0, with a lower value in the challenge group. The breed effect was significant at all stages and the sex effect was not (data not shown). The Quemoy and SPF had high antibody levels from ND0 to ND28. Ju-Chi showed the lowest response to ND vaccination at day 28 post-inoculation.

![**Antibody titers against ND on 0, 14 and 28 days post-inoculation.**^\*^ Nagoya showed a difference of anti-ND antibody titer between the control and challenge groups at day 0, with a lower value in the challenge group.](1753-6561-5-S4-S33-2){#F2}

IBD vaccine response
--------------------

There was a significant effect of breed and no effect of the H6N1 LPAIV challenge on anti-IBD antibody titers at all stages. Interaction between breed and treatment tended to be significant at day 28 (*P* \< 0.05) where the Quemoy was the only one to show significantly lower antibody titers in the challenge group (Fig [3](#F3){ref-type="fig"}). There was a significant sex effect on responses at days 14 and 28 post-inoculation, and the antibody titers were higher in females than in males (data not shown). Nagoya and SPF showed no response to vaccination, but antibody titers of Nagoya were rather high at day 0. Quemoy and Hsin-Yi showed the highest antibody levels, particularly at day 28 post-inoculation. Ju-Chi, Hua-Tung and SPF showed the lowest antibody titers at all stages.

![**Antibody titers against IBD on 0, 14 and 28 days post-inoculation.**^\*^ Quemoy showed significantly lower antibody titer in the challenge group.](1753-6561-5-S4-S33-3){#F3}

IB vaccine response
-------------------

In contrast with the results observed for ND and IBD, the kinetics of antibody titers of IB was modified by the H6N1 LPAIV challenge (Fig [4](#F4){ref-type="fig"}). Interactions between breed and treatment, as well as between breed and sex, were significant for IB0. Antibody titers at day 0 were lower in the challenge group than in the control group for Ju-Chi and SPF, but did not differ between groups for the other breeds (Fig [5](#F5){ref-type="fig"}). The effects of breed and H6N1 challenge, without any interaction, were still observed at day 14 post-inoculation. Higher antibody levels were found in the control group for all breeds. Nagoya was the only one to exhibit a stronger response to IB vaccine in the H6N1 control group at day 14, as measured by the difference between titers at day 14 and day 0 (Table [2](#T2){ref-type="table"}). The interaction between breed and sex was still significant at day 14 but was not observed at day 28. Breed and treatment effects were significant at day 28; antibody titers became higher in the challenge groups than in the control groups, whatever the breed. The increase in antibody titers between day 14 and day 28 was always higher in the challenge groups as compared to the control groups, this difference was highly significant in Ju-Chi and Nagoya (Table [2](#T2){ref-type="table"}) and tended to be significant (*P* \< 0.05) in all other breeds except Shek-Ki which never showed any difference in anti-IB titers between the challenged and the control groups.

![**Antibody titers against IB on 0, 14 and 28 days post-inoculation.**^a,b^ within days post-inoculation with no common superscript differ significantly (*P* \< 0.05).](1753-6561-5-S4-S33-4){#F4}

![**Antibody titers against IB on 0, 14 and 28 days post-inoculation.**^\*^ Antibody titers at day 0 were lower in the challenge group than in the control group for Ju-Chi and SPF. The effects of breed and H6N1 challenge, without any interaction, were still observed at day 14 post-inoculation. Higher antibody levels were found in the control group for all breeds. Nagoya was the only one to exhibit a stronger response to IB vaccine in the H6N1 control group at day 14.](1753-6561-5-S4-S33-5){#F5}

###### 

Effects of H6N1 challenge on antibody titers in different periods across breeds.

  Breed          Period\*    Control         Challenge
  -------------- ----------- --------------- ---------------
  **Hsin-Yi**    IB14-IB0    6253 ± 499      5106 ± 499
                 IB28-IB0    8119 ± 609      8769 ± 609
                 IB28-IB14   1852 ± 726      3722 ± 738
                                             
  **Ju-Chi**     IB14-IB0    4598 ± 553      3374 ± 541
                 IB28-IB0    3474 ± 682^b^   5720 ± 608^a^
                 IB28-IB14   -946 ± 564^b^   2408 ± 564^a^
                                             
  **Hua-Tung**   IB14-IB0    4818 ± 877      3175 ± 784
                 IB28-IB0    7149 ± 604      7461 ± 540
                 IB28-IB14   2331 ± 766      4303 ± 699
                                             
  **Quemoy**     IB14-IB0    3633 ± 508      3424 ± 469
                 IB28-IB0    5261 ± 447      6362 ± 413
                 IB28-IB14   1663 ± 502      2935 ± 463
                                             
  **Shek-Ki**    IB14-IB0    2050 ± 687      1235 ± 615
                 IB28-IB0    9464 ± 623      9809 ± 623
                 IB28-IB14   7148 ± 938      8516 ± 884
                                             
  **Nagoya**     IB14-IB0    6117 ± 548^a^   3165 ± 437^b^
                 IB28-IB0    7038 ± 748      8718 ± 642
                 IB28-IB14   580 ± 844^b^    5433 ± 695^a^
                                             
  **SPF**        IB14-IB0    3205 ± 679      3063 ± 679
                 IB28-IB0    3186 ± 962^b^   6118 ± 962^a^
                 IB28-IB14   -19 ± 1107      3055 ± 1107

^\*^IB14-IB0 represents the difference between IB14 and IB0, IB28-IB0 the difference between IB28 and IB0 and IB28-IB14 the difference between IB28 subtract IB14.

^a,b^ Means ± SE within a breed for a given stage with no common superscript differ significantly (*P* \< 0.05).

Breed comparison showed that Quemoy had the highest antibody titers for IB0. Quemoy, Hsin-Yi and Nagoya had the highest values for IB14. These three breeds had still high values for IB28, but Shek-Ki had also high values for IB28, although it exhibited low values for IB0 and IB14. Thus, this breed was characterized by a late and strong response to IB vaccine, without any significant effect of the previous H6N1 challenge.

Discussion and conclusions
==========================

H6N1 LPAIV challenge effect
---------------------------

Mortality data and the increased antibody titers of challenge group at day 14 post-challenge showed that the challenge test had been effective. Estimation of breed effects may be affected by limited sample size, particularly for Shek-Ki, SPF and Nagoya. However, Quemoy had the largest sample size, and can be identified as the most resistant breed since it did not show any mortality after the challenge, and exhibited the most rapid immune response at day 7 post-challenge. At the opposite, Hsin-Yi can be identified as the most susceptible breed, with a rather high mortality (7 birds out of 26) in spite of the use of a low pathogenic virus.

Breeds effect, vaccine efficacy and duration of immunity
--------------------------------------------------------

Antibodies were detected for ND, IB and IBD at day 0 post-inoculation because all chickens had been vaccinated for ND, IB and IBD at earlier ages. Thus, the immune response following the inoculation at 11 weeks of age may be considered as a secondary immune response. Antibody titers at day 14 post-inoculation were significantly higher than at day 0, showing vaccine efficiency, except in the case of Nagoya and SPF for IBD vaccine where no change in antibody levels was observed.

Breed significantly affected immune response. Quemoy had high and rapid responses to the three vaccines and to H6N1 LPAVI challenge test, in contrast to Ju-Chi which had low immune response to vaccines and challenge test. Breed's effect on the antibody titers at day 0 revealed differences in the duration of immunity to previous vaccines. Quemoy appeared to have a better immunity than other breeds, Shek-Ki had a slow response to ND and IB, and Ju-Chi presented lowest response to IBD. The better immune response of Quemoy is consistent with previous results \[[@B2]\].

H6N1 LPAIV challenge effect on IB immune response
-------------------------------------------------

H6N1 LPAIV challenge had a negative effect on antibody levels to IB even before the vaccination at 11 weeks of age. Immune response to IB vaccine took place in H6N1 challenge groups with some delay (after 14 days). The negative relationship of H6N1 LPAIV challenge and IB vaccine response could be related to the fact that both viruses target the lung tissues. Recently, Haghighat-Jahromi et al. \[[@B4]\] showed that coinfection of H9N2 AI virus with IB live virus enhanced the virulence of H9N2 and increased the rate of mortality. In addition, Karimi-Madab et al. \[[@B5]\] showed that IB live vaccine could be an important risk factor resulting in enhanced virulence of H9N2 LPAIV in field conditions. Although these studies were focusing on broilers and H9N2 LPAIV, the present study shows also an interaction between IB and H6N1 LPAIV infection in some local chicken breeds. One could speculate that the type of local immune response induced by H6N1 LPAIV infection was not favourable for birds to make optimum IB-specific antibody response.

In conclusion, local breeds have different immune response to H6N1 LPAIV challenge and subsequent vaccines. The H6N1 LPAIV challenge influenced the response to subsequent vaccination against IB, but had no effect on ND and IBD subsequent vaccines.
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